IMB Dx is a precision oncology company that strives to implement precision medicine and offers technologies for cancer diagnosis through analysis of tumor DNA in the blood. As the name IMB Dx (In My Blood Diagnostics) suggests, our expertise lies in liquid biopsy using blood. We are committed to understanding cancer with our advanced, proprietary technology. The AlphaLiquid® test aims to provide useful information to cancer patients and their families as well as medical professionals around the world. We are revolutionizing the way cancer is diagnosed, treated and monitored.